Bizarre Patents
A coffin, for allowing inclination for display of a deceased person in a natural position.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20110039794 | Long Acting Injectable Formulations Long acting injectable formulations of macrocyclic lactones comprising a biologically acceptable and biodegradable polyester polymer in a solvent system for use in the field of veterinary medicine, especially for use in combating ecto- and endoparasites in animals.... | 02/17/2011 |
| 20110033497 | VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARIS, MYCOPLASMA HYOPNEUMONIAE AND PORCINE CIRCO VIRUS The present invention pertains to a vaccine comprising in combination non-live antigens of Lawsonia intracellularis, of Mycoplasma hyopneumniae and Porcine circo virus, and a pharmaceutically acceptable carrier. The invention also pertains to a kit compris... | 02/10/2011 |
| 20110033496 | VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARS The present invention pertains to the use of a non-live carbohydrate containing composition, the carbohydrate being also found in live Lawsonia intracellularis cells in association with the outer cell membrane of these cells, for the manufacture of a vaccine for ... | 02/10/2011 |
| 20110027308 | COMPOSITIONS AND METHODS FOR PREVENTING INFLUENZA INFECTION IN CANINES, FELINES AND EQUINES The present invention is directed to the use of recombinant, chimeric mononegavirale vectors comprising a foreign gene. More particularly, the present invention is directed to the use of such vectors for treating respiratory diseases in canines, felines or equines. An e... | 02/03/2011 |
| 20110027222 | Vaccine for the Treatment of Osteoarthritis The present invention pertains to a vaccine for the treatment of osteoarthritis in a vertebrate comprising IL-1β and optionally TNF-α cytokines or derivatives thereof, and in association with said IL-1β and optional TNF-α or derivatives thereof a part that is non-se... | 02/03/2011 |
| 20110021506 | ANTHELMINTIC AGENTS AND THEIR USE This invention is directed to compounds and salts that are generally useful as anthelmintic agents or as intermediates in processes for making anthelmintic agents. This invention also is directed to processes for making the compounds and salts, pharmaceutical compositio... | 01/27/2011 |
| 20110016740 | Method for lyophilising particles having a pharmaceutical compound contained therein and a pharmaceutical pack containing such particles The present invention pertains to a method for lyophilising particles comprising frozen liquid having a pharmaceutical compound contained therein, comprising providing a heat conducting container having a bottom and side walls, filling the container with a bed of the pa... | 01/27/2011 |
| 20110014237 | Vaccine for Protection Against Haemophilus Parasuis Serotype 4 in Piglets The present invention pertains to the use of Haemophilus parasuis serotype 5 bacteria in the manufacture of a vaccine for administration to a pregnant sow or gilt, to protect a piglet through the intake of colostrum of the said sow or gilt after she has farrowed,... | 01/20/2011 |
| 20100331376 | Process for Recovering Flunixin From Pharmaceutical Compositions This invention is generally directed to a method for recovering flunixin and flunixin analogs from pharmaceutical compositions. The recovered flunixin and analogs can be, for example, reused to make new pharmaceutical compositions and thereby reduce the need and expense... | 12/30/2010 |
| 20100324125 | Proteins derived from white spot syndrome virus and uses thereof Embodiments of the present invention generally relate to proteins derived from white spot syndrome virus, nucleic acid sequences encoding them, and their use in the manufacture of a vaccine for prophylaxis and/or treatment of white spot syndrome in crustaceans.... | 12/23/2010 |
| 20100260795 | Carrier Particle for a Microorganism or Subunit Thereof, Pharmaceutical Composition Comprising such Particles, Method for Preparation of this Composition and Its Use in the Treatment of Animals The invention pertains to a carrier particle comprising a hydrophilic phase containing a micro-organism and/or subunit thereof, the hydrophilic phase being dispersed in a hydrophobic continuous phase being solid at room temperature, wherein the hydrophobic phase is cons... | 10/14/2010 |
| 20100233208 | Methods of Treating and Preventing Neurological Symptoms Caused by Avian Reovirus and Novel Associated Characteristics Embodiments of the present invention generally relate to novel methods for the treatment and/or prevention of neurological symptoms caused by an avian reovirus, enteric reovirus strain (ERS), and associated characteristics. Other embodiments generally comprise and immun... | 09/16/2010 |
| 20100210851 | PROCESS FOR PREPARING OXAZOLIDINE- AND OXAZOLIDINONE-AMINODIOLS A method of preparing oxazolidine-protected and oxazolidinone-protected aminodiol compounds is disclosed. These compounds tend to be useful as intermediates in processes for making Florfenicol and related compounds.... | 08/19/2010 |
| 20100209446 | Ostertagia Vaccine The present invention relates to nucleic acid sequences encoding a 30 kD Brachyspira hyodysenteriae lipoprotein and to parts of such nucleic acid sequences that encode an immunogenic fragment of such lipoproteins, and to DNA fragments, recombinant DNA molecules, ... | 08/19/2010 |
| 20100130960 | Method for intranasal administration of a pharmaceutical composition Please insert the attached Abstract provided herewith on a separate sheet after the claims. The present invention pertains to a method for administering a predetermined amount of a pharmaceutical composition to an animal comprising the steps of taking a cannula suitable... | 05/27/2010 |
| 20100111997 | Multi component vaccine containing clostridial and non-clostridial organisms in a low dose Disclosed herein is a multicomponent low dose vaccine comprising a safe and immunogenically effective combination of a protective antigen component or components of clostridial organism, a protective antigen component of a non-clostridial organism and an adjuvant.... | 05/06/2010 |
| 20100062025 | Use of Clostridium perfringens type C bacterium for the manufacture of a vaccine The present invention relates to the use of a vaccine comprising Clostridium perfringens type C bacterium for protecting swine against Clostridium perfringens type A infection.... | 03/11/2010 |
| 20100062017 | Pasteurella multocida vaccine The present invention relates to live attenuated bacteria of the species Pasteurella multocida, to live attenuated vaccines comprising such live attenuated bacteria, to the use of such bacteria for the manufacture of such vaccines, to methods for the preparation ... | 03/11/2010 |
| 20100047272 | Therapeutic vaccine comprising mycobacterial heat shock protein 70 The present invention relates to the use of a mycobacterial heat-shock protein for the manufacture of a vaccine for therapeutic application.... | 02/25/2010 |
| 20100028383 | Chemically defined stabiliser The present invention relates to a stabiliser composition comprising an amino acid, and a sugar wherein all compounds are chemically defined; to a vaccine composition comprising such a stabiliser composition and a biological molecule and/or a micro-organism; to a method... | 02/04/2010 |
| 20100008945 | Recombinant Newcastle Disease Virus Expressing H5 Hemagglutinin of Avian Influenza Virus The present invention provides a method to produce a recombinant Mononegavirales virus vector harbouring an additional transcription unit comprising a foreign gene operatively linked with an upstream Mononegavirales virus gene start (GS) sequence and a downstream Monone... | 01/14/2010 |
| 20100003284 | Live attenuated aldolase-negative bacterial vaccine A live attenuated bacterium of the genus Escherichia, Salmonella or Yersinia, said bacterium being incapable of expressing a functional Eda protein as a result of a mutation in the eda gene and a vaccine comprising the live attenuated bacterium.... | 01/07/2010 |
| 20090304737 | Vaccine Against Mycoplasma PRRSV The present invention relates to the use of an immunogenic dose of immunogenic material of Mycoplasma hyopneumoniae and an immunogenic dose of live attenuated PRRS virus for the manufacture of a vaccine, and to a vaccine kit comprising such a vaccine.... | 12/10/2009 |
| 20090275662 | Injectable veterinary composition Injectable veterinary composition comprising a fluorinated chloramphenicol or thiamphenicol derivative and a solvent system comprising an ether of 1,2-ethanediol oligo- or polymers, and a pyrrolidone solvent.... | 11/05/2009 |
| 20090270507 | Concentrated Liquid Thyroid Hormone Composition This invention is directed generally to a liquid pharmaceutical composition comprising at least one thyroid hormone (particularly a composition further comprising at least one cyclodextrin compound), a process for making such a composition and a method of using such a c... | 10/29/2009 |
| 20090263419 | Live attenuated bacterial vaccine A live, attenuated bacterium of the genus Escherichia, Yersinia or Salmonella, that does not have a functional tRNA5leu, and vaccines comprising the live, attenuated bacterium.... | 10/22/2009 |
| 20090246223 | Inactivated Chimeric Vaccines and Related Methods of Use Embodiments of the present invention generally provide an inactivated chimeric virus vaccine and/or immunogenic composition for the treatment or prevention of viral infection. Further, various other embodiments of the present invention generally relate to methods of pre... | 10/01/2009 |
| 20090238844 | Porcine reproductive and respiratory syndrome virus strains and compositions This invention relates to two attenuated strains of porcine reproductive and respiratory syndrome virus (PRRSV) and immunogenic compositions comprising one or more strains of attenuated porcine reproductive and respiratory syndrome virus (PRRSV).... | 09/24/2009 |
